Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer

计划入组 16 人 · 首次发布于 2008 年 9 月 18 日

A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer

计划入组 9 人 · 首次发布于 2007 年 6 月 12 日

Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

计划入组 90 人 · 首次发布于 2007 年 2 月 27 日

12A6-DM1

anti-HER2/HER3 dendritic cell vaccine

Tucatinib(Tukysa)

C₂₆H₂₄N₈O₂ · Rx

JAPAN BREAST CANCER RESEARCH GROUP

Japan

ANZ BREAST CANCER TRIALS GROUP LIMITED

Australia

International Breast Cancer Research Foundation

United States

Brazil-India Partnership Advances Pertuzumab Development for HER-2 Metastatic Breast Cancer

FDA Clears Delcath's HEPZATO for Phase 2 Trial in Liver-Dominant Metastatic Breast Cancer

Olema Oncology and Pfizer Launch Phase 1b/2 Trial Combining Palazestrant with Atirmociclib for ER+/HER2- Metastatic Breast Cancer